NEU 6.41% $15.27 neuren pharmaceuticals limited

ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-103

  1. 1,646 Posts.
    lightbulb Created with Sketch. 1475
    As a Health Professional I feel for Anavex who are trying to do good things.

    As a Neuren stakeholder of course I am absolutely thrilled. Very important too as mentioned that the trial participants can now access Daybue with our substantive proven benefits.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.